David Freiholtz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David Freiholtz has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Hanna M. Björck
Cardiology Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
4 shared publications Anders Franco-Cereceda
Section of Cardiothoracic Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet
2 shared publications- Anton Gisterå
Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Cecilia Österholm
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
2 shared publications - Christian Olsson
Department of Molecular Medicine and Surgery, Karolinska Institute
2 shared publications - Karin Lång
Division of Cardiology, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Karolinska University Hospital, Solna, Sweden (D.F., C.R.-G., K.L., O.B., P.E., H.M.B.).
2 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by Karolinska Institutet
Ascending aortic aneurysm : implications of aortic valve phenotype
BACKGROUND: An ascending aortic aneurysm (AscAA) is a silent, potentially fatal condition, as it increases the risk of aortic wall failure through dissection or rupture. With an increasing prevalence, aortic disease now occupies the position of the 19th leading cause of death in the United States. Surgical intervention is indicated when the diameter exceeds 55 mm, or at smaller diameters in the presence of comorbidities or high-risk clinical features. While elective surgical treatment is prophylactic, many who present with catastrophic acute aortic failure do so at diameters below these surgical criteria. As current guideline thresholds rely primarily on aortic diameter, these strategies remain blind to the underlying aortic biology that determines rates of disease progression. Furthermore, there is currently no targeted medical treatment.AscAA encompasses multiple aetiologies with the same clinical manifestation - a dilatation of the ascending aortic segment. Discernible aetiologies, including syndromic disease and familial thoracic aortopathies, are increasingly found in clinical practice but are at the present time expected to make up 20-23% of surgical cohorts. The two most prevalent forms of AscAA are the degenerative AscAA, and the form manifesting in patients with a bicuspid aortic valve (BAV) - the most common (about 0.5-1.4% of the general population) congenital malformation of the heart valves. While the mechanisms of disease for these two forms are not fully known, multiple lines of evidence suggest different molecular and histopathological phenotypes.AIMS: This thesis aims to develop new insights into AscAA pathogenesis from molecular, cellular, and translational perspectives, with a focus on degenerative and BAV-associated forms. Specifically, the thesis aims to characterise endothelial-to-mesenchymal transition (EndMT) in degenerative and BAV-associated aortopathy. Additional aims include identification of drivers of fibrotic and inflammatory remodelling, investigation of mechanisms linking aortic valve disease to early aortic wall pathology, and evaluation of whether transcriptomic subtypes of ascending aortic tissue inform post-operative clinical heterogeneity.MATERIALS AND METHODS: Across all studies, investigations were primarily conducted in two cohorts of patients undergoing open heart surgery for either ascending aortic surgery, aortic valve replacement or both at the Karolinska University Hospital in Solna, Sweden. For the first cohort, operated between 2007 and 2013, patients were recontacted to inquire about participation in a 10-year radiological follow-up. For the majority of patients in this cohort, retrospective information on death and aortic events was collected through the medical records. The second cohort was started in 2012 and is still ongoing. In both cohorts, biological samples were collected from dilated and non-dilated ascending aortas, as well as plasma and whole blood. Human aortic tissue was used for transcriptomic exon arrays, spatial transcriptomics, proteomics, and primary cell isolation. In-house data on physiological rat aortic expression was used, and external single-cell matrices were produced from cohorts in Munich, Germany for cellular deconvolution.RESULTS: In study I we found that EndMT processes specific to BAV-associated AscAA had similar characteristics to embryonic EndMT, and we found a loss of canonical endothelial function in BAV-associated aortas even in the absence of dilatation, as evidenced by loss of CD31, decreased endothelial laminin y1, and subintimal accumulation of albumin as a proxy for endothelial permeability. In study II, the EndMT process was seemingly driven by osteopontin, in part expressed by CD68-positive cells. The expression of osteopontin may be regulated by distal enhancers affected by the transcription factor ETS1, in the context of inflammatory cells. This regulatory function could further be validated by cellular perturbations and in degenerative AscAA tissue. In study III, following up on the inflammatory phenotype of degenerative AscAA, we observed an association of nascent subintimal oxLDL and endothelial activation in non-dilated aortas of patients with aortic regurgitation, with potential downstream effects exacerbating inflammatory activity by CD68-positive cells. When following a subset of patients having undergone aortic valve replacement, we found that those who were operated for aortic regurgitation did not continue to grow, but patients with aortic stenosis (who rarely develop degenerative AscAA) did grow. Data from the follow-up on patients undergoing aortic valve and/or ascending aortic surgery was then leveraged in study IV to identify context-agnostic transcriptomic subtypes of aortic expression associated with late aortic events. We identified a subset of degenerative AscAA with a particularly inflammatory gene expression profile, which was associated with a significantly higher risk of residual disease through aneurysm development in the remaining ascending aorta. This subtype may be distinguishable from other degenerative AscAA through blood-borne plasma proteins.CONCLUSIONS: This thesis demonstrates that AscAA comprises biologically distinct disease processes linked to aortic valve phenotype. Endothelial dysfunction emerges as an early and central feature in both BAV-associated and degenerative AscAA; however, the underlying disease programs differ. BAV-associated aortopathy is characterised by features consistent with developmental endothelial dysfunction, whereas degenerative AscAA is more closely associated with endothelial activation, inflammation, and fibrotic degeneration. In degenerative AscAA, inflammatory activity may persist beyond the resected aortic segment and be associated with residual post-operative aortic risk. Collectively, these findings suggest that biologically informed approaches may complement current diameter-based guidelines in the future management of...
- 28 April 2026
- Published by Karolinska Institutet
Open AccessAscending aortic aneurysm : implications of aortic valve phenotype
BACKGROUND: An ascending aortic aneurysm (AscAA) is a silent, potentially fatal condition, as it increases the risk of aortic wall failure through dissection or rupture. With an increasing prevalence, aortic disease now occupies the position of the 19th leading cause of death in the United States. Surgical intervention is indicated when the diameter exceeds 55 mm, or at smaller diameters in the presence of comorbidities or high-risk clinical features. While elective surgical treatment is prophylactic, many who present with catastrophic acute aortic failure do so at diameters below these surgical criteria. As current guideline thresholds rely primarily on aortic diameter, these strategies remain blind to the underlying aortic biology that determines rates of disease progression. Furthermore, there is currently no targeted medical treatment.AscAA encompasses multiple aetiologies with the same clinical manifestation - a dilatation of the ascending aortic segment. Discernible aetiologies, including syndromic disease and familial thoracic aortopathies, are increasingly found in clinical practice but are at the present time expected to make up 20-23% of surgical cohorts. The two most prevalent forms of AscAA are the degenerative AscAA, and the form manifesting in patients with a bicuspid aortic valve (BAV) - the most common (about 0.5-1.4% of the general population) congenital malformation of the heart valves. While the mechanisms of disease for these two forms are not fully known, multiple lines of evidence suggest different molecular and histopathological phenotypes.AIMS: This thesis aims to develop new insights into AscAA pathogenesis from molecular, cellular, and translational perspectives, with a focus on degenerative and BAV-associated forms. Specifically, the thesis aims to characterise endothelial-to-mesenchymal transition (EndMT) in degenerative and BAV-associated aortopathy. Additional aims include identification of drivers of fibrotic and inflammatory remodelling, investigation of mechanisms linking aortic valve disease to early aortic wall pathology, and evaluation of whether transcriptomic subtypes of ascending aortic tissue inform post-operative clinical heterogeneity.MATERIALS AND METHODS: Across all studies, investigations were primarily conducted in two cohorts of patients undergoing open heart surgery for either ascending aortic surgery, aortic valve replacement or both at the Karolinska University Hospital in Solna, Sweden. For the first cohort, operated between 2007 and 2013, patients were recontacted to inquire about participation in a 10-year radiological follow-up. For the majority of patients in this cohort, retrospective information on death and aortic events was collected through the medical records. The second cohort was started in 2012 and is still ongoing. In both cohorts, biological samples were collected from dilated and non-dilated ascending aortas, as well as plasma and whole blood. Human aortic tissue was used for transcriptomic exon arrays, spatial transcriptomics, proteomics, and primary cell isolation. In-house data on physiological rat aortic expression was used, and external single-cell matrices were produced from cohorts in Munich, Germany for cellular deconvolution.RESULTS: In study I we found that EndMT processes specific to BAV-associated AscAA had similar characteristics to embryonic EndMT, and we found a loss of canonical endothelial function in BAV-associated aortas even in the absence of dilatation, as evidenced by loss of CD31, decreased endothelial laminin y1, and subintimal accumulation of albumin as a proxy for endothelial permeability. In study II, the EndMT process was seemingly driven by osteopontin, in part expressed by CD68-positive cells. The expression of osteopontin may be regulated by distal enhancers affected by the transcription factor ETS1, in the context of inflammatory cells. This regulatory function could further be validated by cellular perturbations and in degenerative AscAA tissue. In study III, following up on the inflammatory phenotype of degenerative AscAA, we observed an association of nascent subintimal oxLDL and endothelial activation in non-dilated aortas of patients with aortic regurgitation, with potential downstream effects exacerbating inflammatory activity by CD68-positive cells. When following a subset of patients having undergone aortic valve replacement, we found that those who were operated for aortic regurgitation did not continue to grow, but patients with aortic stenosis (who rarely develop degenerative AscAA) did grow. Data from the follow-up on patients undergoing aortic valve and/or ascending aortic surgery was then leveraged in study IV to identify context-agnostic transcriptomic subtypes of aortic expression associated with late aortic events. We identified a subset of degenerative AscAA with a particularly inflammatory gene expression profile, which was associated with a significantly higher risk of residual disease through aneurysm development in the remaining ascending aorta. This subtype may be distinguishable from other degenerative AscAA through blood-borne plasma proteins.CONCLUSIONS: This thesis demonstrates that AscAA comprises biologically distinct disease processes linked to aortic valve phenotype. Endothelial dysfunction emerges as an early and central feature in both BAV-associated and degenerative AscAA; however, the underlying disease programs differ. BAV-associated aortopathy is characterised by features consistent with developmental endothelial dysfunction, whereas degenerative AscAA is more closely associated with endothelial activation, inflammation, and fibrotic degeneration. In degenerative AscAA, inflammatory activity may persist beyond the resected aortic segment and be associated with residual post-operative aortic risk. Collectively, these findings suggest that biologically informed approaches may complement current diameter-based guidelines in the future management of...
- Open Access
- 28 April 2026
- Published by Karolinska Institutet
Ascending aortic aneurysm : implications of aortic valve phenotype
BACKGROUND: An ascending aortic aneurysm (AscAA) is a silent, potentially fatal condition, as it increases the risk of aortic wall failure through dissection or rupture. With an increasing prevalence, aortic disease now occupies the position of the 19th leading cause of death in the United States. Surgical intervention is indicated when the diameter exceeds 55 mm, or at smaller diameters in the presence of comorbidities or high-risk clinical features. While elective surgical treatment is prophylactic, many who present with catastrophic acute aortic failure do so at diameters below these surgical criteria. As current guideline thresholds rely primarily on aortic diameter, these strategies remain blind to the underlying aortic biology that determines rates of disease progression. Furthermore, there is currently no targeted medical treatment.AscAA encompasses multiple aetiologies with the same clinical manifestation - a dilatation of the ascending aortic segment. Discernible aetiologies, including syndromic disease and familial thoracic aortopathies, are increasingly found in clinical practice but are at the present time expected to make up 20-23% of surgical cohorts. The two most prevalent forms of AscAA are the degenerative AscAA, and the form manifesting in patients with a bicuspid aortic valve (BAV) - the most common (about 0.5-1.4% of the general population) congenital malformation of the heart valves. While the mechanisms of disease for these two forms are not fully known, multiple lines of evidence suggest different molecular and histopathological phenotypes.AIMS: This thesis aims to develop new insights into AscAA pathogenesis from molecular, cellular, and translational perspectives, with a focus on degenerative and BAV-associated forms. Specifically, the thesis aims to characterise endothelial-to-mesenchymal transition (EndMT) in degenerative and BAV-associated aortopathy. Additional aims include identification of drivers of fibrotic and inflammatory remodelling, investigation of mechanisms linking aortic valve disease to early aortic wall pathology, and evaluation of whether transcriptomic subtypes of ascending aortic tissue inform post-operative clinical heterogeneity.MATERIALS AND METHODS: Across all studies, investigations were primarily conducted in two cohorts of patients undergoing open heart surgery for either ascending aortic surgery, aortic valve replacement or both at the Karolinska University Hospital in Solna, Sweden. For the first cohort, operated between 2007 and 2013, patients were recontacted to inquire about participation in a 10-year radiological follow-up. For the majority of patients in this cohort, retrospective information on death and aortic events was collected through the medical records. The second cohort was started in 2012 and is still ongoing. In both cohorts, biological samples were collected from dilated and non-dilated ascending aortas, as well as plasma and whole blood. Human aortic tissue was used for transcriptomic exon arrays, spatial transcriptomics, proteomics, and primary cell isolation. In-house data on physiological rat aortic expression was used, and external single-cell matrices were produced from cohorts in Munich, Germany for cellular deconvolution.RESULTS: In study I we found that EndMT processes specific to BAV-associated AscAA had similar characteristics to embryonic EndMT, and we found a loss of canonical endothelial function in BAV-associated aortas even in the absence of dilatation, as evidenced by loss of CD31, decreased endothelial laminin y1, and subintimal accumulation of albumin as a proxy for endothelial permeability. In study II, the EndMT process was seemingly driven by osteopontin, in part expressed by CD68-positive cells. The expression of osteopontin may be regulated by distal enhancers affected by the transcription factor ETS1, in the context of inflammatory cells. This regulatory function could further be validated by cellular perturbations and in degenerative AscAA tissue. In study III, following up on the inflammatory phenotype of degenerative AscAA, we observed an association of nascent subintimal oxLDL and endothelial activation in non-dilated aortas of patients with aortic regurgitation, with potential downstream effects exacerbating inflammatory activity by CD68-positive cells. When following a subset of patients having undergone aortic valve replacement, we found that those who were operated for aortic regurgitation did not continue to grow, but patients with aortic stenosis (who rarely develop degenerative AscAA) did grow. Data from the follow-up on patients undergoing aortic valve and/or ascending aortic surgery was then leveraged in study IV to identify context-agnostic transcriptomic subtypes of aortic expression associated with late aortic events. We identified a subset of degenerative AscAA with a particularly inflammatory gene expression profile, which was associated with a significantly higher risk of residual disease through aneurysm development in the remaining ascending aorta. This subtype may be distinguishable from other degenerative AscAA through blood-borne plasma proteins.CONCLUSIONS: This thesis demonstrates that AscAA comprises biologically distinct disease processes linked to aortic valve phenotype. Endothelial dysfunction emerges as an early and central feature in both BAV-associated and degenerative AscAA; however, the underlying disease programs differ. BAV-associated aortopathy is characterised by features consistent with developmental endothelial dysfunction, whereas degenerative AscAA is more closely associated with endothelial activation, inflammation, and fibrotic degeneration. In degenerative AscAA, inflammatory activity may persist beyond the resected aortic segment and be associated with residual post-operative aortic risk. Collectively, these findings suggest that biologically informed approaches may complement current diameter-based guidelines in the future management of...
- 28 April 2026
- Published by Karolinska Institutet
Open AccessAscending aortic aneurysm : implications of aortic valve phenotype
BACKGROUND: An ascending aortic aneurysm (AscAA) is a silent, potentially fatal condition, as it increases the risk of aortic wall failure through dissection or rupture. With an increasing prevalence, aortic disease now occupies the position of the 19th leading cause of death in the United States. Surgical intervention is indicated when the diameter exceeds 55 mm, or at smaller diameters in the presence of comorbidities or high-risk clinical features. While elective surgical treatment is prophylactic, many who present with catastrophic acute aortic failure do so at diameters below these surgical criteria. As current guideline thresholds rely primarily on aortic diameter, these strategies remain blind to the underlying aortic biology that determines rates of disease progression. Furthermore, there is currently no targeted medical treatment.AscAA encompasses multiple aetiologies with the same clinical manifestation - a dilatation of the ascending aortic segment. Discernible aetiologies, including syndromic disease and familial thoracic aortopathies, are increasingly found in clinical practice but are at the present time expected to make up 20-23% of surgical cohorts. The two most prevalent forms of AscAA are the degenerative AscAA, and the form manifesting in patients with a bicuspid aortic valve (BAV) - the most common (about 0.5-1.4% of the general population) congenital malformation of the heart valves. While the mechanisms of disease for these two forms are not fully known, multiple lines of evidence suggest different molecular and histopathological phenotypes.AIMS: This thesis aims to develop new insights into AscAA pathogenesis from molecular, cellular, and translational perspectives, with a focus on degenerative and BAV-associated forms. Specifically, the thesis aims to characterise endothelial-to-mesenchymal transition (EndMT) in degenerative and BAV-associated aortopathy. Additional aims include identification of drivers of fibrotic and inflammatory remodelling, investigation of mechanisms linking aortic valve disease to early aortic wall pathology, and evaluation of whether transcriptomic subtypes of ascending aortic tissue inform post-operative clinical heterogeneity.MATERIALS AND METHODS: Across all studies, investigations were primarily conducted in two cohorts of patients undergoing open heart surgery for either ascending aortic surgery, aortic valve replacement or both at the Karolinska University Hospital in Solna, Sweden. For the first cohort, operated between 2007 and 2013, patients were recontacted to inquire about participation in a 10-year radiological follow-up. For the majority of patients in this cohort, retrospective information on death and aortic events was collected through the medical records. The second cohort was started in 2012 and is still ongoing. In both cohorts, biological samples were collected from dilated and non-dilated ascending aortas, as well as plasma and whole blood. Human aortic tissue was used for transcriptomic exon arrays, spatial transcriptomics, proteomics, and primary cell isolation. In-house data on physiological rat aortic expression was used, and external single-cell matrices were produced from cohorts in Munich, Germany for cellular deconvolution.RESULTS: In study I we found that EndMT processes specific to BAV-associated AscAA had similar characteristics to embryonic EndMT, and we found a loss of canonical endothelial function in BAV-associated aortas even in the absence of dilatation, as evidenced by loss of CD31, decreased endothelial laminin y1, and subintimal accumulation of albumin as a proxy for endothelial permeability. In study II, the EndMT process was seemingly driven by osteopontin, in part expressed by CD68-positive cells. The expression of osteopontin may be regulated by distal enhancers affected by the transcription factor ETS1, in the context of inflammatory cells. This regulatory function could further be validated by cellular perturbations and in degenerative AscAA tissue. In study III, following up on the inflammatory phenotype of degenerative AscAA, we observed an association of nascent subintimal oxLDL and endothelial activation in non-dilated aortas of patients with aortic regurgitation, with potential downstream effects exacerbating inflammatory activity by CD68-positive cells. When following a subset of patients having undergone aortic valve replacement, we found that those who were operated for aortic regurgitation did not continue to grow, but patients with aortic stenosis (who rarely develop degenerative AscAA) did grow. Data from the follow-up on patients undergoing aortic valve and/or ascending aortic surgery was then leveraged in study IV to identify context-agnostic transcriptomic subtypes of aortic expression associated with late aortic events. We identified a subset of degenerative AscAA with a particularly inflammatory gene expression profile, which was associated with a significantly higher risk of residual disease through aneurysm development in the remaining ascending aorta. This subtype may be distinguishable from other degenerative AscAA through blood-borne plasma proteins.CONCLUSIONS: This thesis demonstrates that AscAA comprises biologically distinct disease processes linked to aortic valve phenotype. Endothelial dysfunction emerges as an early and central feature in both BAV-associated and degenerative AscAA; however, the underlying disease programs differ. BAV-associated aortopathy is characterised by features consistent with developmental endothelial dysfunction, whereas degenerative AscAA is more closely associated with endothelial activation, inflammation, and fibrotic degeneration. In degenerative AscAA, inflammatory activity may persist beyond the resected aortic segment and be associated with residual post-operative aortic risk. Collectively, these findings suggest that biologically informed approaches may complement current diameter-based guidelines in the future management of...
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (9) , 1636-1647
Tricuspid Aortic Valve Regurgitation Associates With Ascending Aortic Aneurysm Through Endothelial Activation and Lipoprotein Infiltration
BACKGROUND: An abnormal accumulation of immune cells and inflammation has been described in ascending aortic aneurysm, but the factor driving disease initiation remains elusive. Interestingly, ascending aortic dilatation often occurs alongside aortic regurgitation but rarely with aortic stenosis. We sought to investigate ascending aortic aneurysm initiation by assessing the relation between aortic regurgitation and vascular activation and inflammation. METHODS: In this prospective cohort study, patients with tricuspid aortic valves undergoing elective open-heart surgery were included. Aortic specimens from organ donors were obtained through the University of Miami Tissue Bank. Spatial transcriptomics measured gene expression in nondilated aortic endothelium, intima, and subintima. Immunohistochemistry determined protein expression. Aortic dimensions were recorded preoperatively and 10 years after surgery using echocardiography. Aortic gene expression affected by physiological blood flow was previously measured in Wistar rats. RESULTS: We show a mesenchymal activation of endothelial cells, possibly mediated by bidirectional flow, in the nondilated ascending aorta of patients with aortic regurgitation, accompanied by intimal infiltration, retention, and oxidation of apoB-containing lipoproteins. We further observed intimal upregulation of genes coding for core proteins of lipoprotein-binding proteoglycans and the OLR1 (oxidized low-density lipoprotein receptor 1), the latter by infiltrating macrophages and in association with progressive inflammation and dilatation. None of the above was observed in patients with aortic stenosis. Notably, surgical replacement of regurgitant valves, but not stenotic valves, mitigated 10-year aortic growth. CONCLUSIONS: Our results highlight a distinct pathological role of aortic regurgitation in ascending aortic aneurysm formation by promoting mesenchymal activation of endothelial cells and lipoprotein-related immune cell infiltration and inflammation in patients with tricuspid aortic valves. We also provide novel insights into the long-term impact of surgical aortic valve replacement on ascending aortic growth and suggest a diagnostic or therapeutic target in oxidized low-density lipoprotein cholesterol.
- 1 September 2025
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 45 (9) , 1636-1647
Open AccessTricuspid Aortic Valve Regurgitation Associates With Ascending Aortic Aneurysm Through Endothelial Activation and Lipoprotein Infiltration
BACKGROUND: An abnormal accumulation of immune cells and inflammation has been described in ascending aortic aneurysm, but the factor driving disease initiation remains elusive. Interestingly, ascending aortic dilatation often occurs alongside aortic regurgitation but rarely with aortic stenosis. We sought to investigate ascending aortic aneurysm initiation by assessing the relation between aortic regurgitation and vascular activation and inflammation. METHODS: In this prospective cohort study, patients with tricuspid aortic valves undergoing elective open-heart surgery were included. Aortic specimens from organ donors were obtained through the University of Miami Tissue Bank. Spatial transcriptomics measured gene expression in nondilated aortic endothelium, intima, and subintima. Immunohistochemistry determined protein expression. Aortic dimensions were recorded preoperatively and 10 years after surgery using echocardiography. Aortic gene expression affected by physiological blood flow was previously measured in Wistar rats. RESULTS: We show a mesenchymal activation of endothelial cells, possibly mediated by bidirectional flow, in the nondilated ascending aorta of patients with aortic regurgitation, accompanied by intimal infiltration, retention, and oxidation of apoB-containing lipoproteins. We further observed intimal upregulation of genes coding for core proteins of lipoprotein-binding proteoglycans and the OLR1 (oxidized low-density lipoprotein receptor 1), the latter by infiltrating macrophages and in association with progressive inflammation and dilatation. None of the above was observed in patients with aortic stenosis. Notably, surgical replacement of regurgitant valves, but not stenotic valves, mitigated 10-year aortic growth. CONCLUSIONS: Our results highlight a distinct pathological role of aortic regurgitation in ascending aortic aneurysm formation by promoting mesenchymal activation of endothelial cells and lipoprotein-related immune cell infiltration and inflammation in patients with tricuspid aortic valves. We also provide novel insights into the long-term impact of surgical aortic valve replacement on ascending aortic growth and suggest a diagnostic or therapeutic target in oxidized low-density lipoprotein cholesterol.
- Open Access
Global Trends and Risk Factors of Aortic Aneurysm Mortality from 1990 to 2021: An Analysis of the Global Burden of Disease Study 2021
Background Aortic aneurysm (AA) is a life-threatening disease with significant global burden. Objectives This study aims to evaluate epidemiological trends and risk factors for AA-related mortality from 1990 to 2021 across regions, accounting for age, sex, and socio-economic factors. Methods Using Global Burden of Disease (GBD) Study 2021, we analyzed AA-related death, death rates, and the age-standardized AA-related death rate (ASDR) per 100,000, along with risk factors. Trends from 1990 to 2021 were compared across global regions and countries by socio-demographic index, health systems, and income. We also examined the impact and trend changes of age, sex, and risk factors on AA. Results In 2021, global AA-related deaths reached 153,927 (95% uncertainty intervals (UI): 138,413-165,738), a 74.2% increase from 1990. However, accounting for changes in population size and age, ASDR declined from 2.54 (95%UI: 2.35-2.69) to 1.86 (95%UI: 1.67-2.00) deaths per 100,000 people. Europe and America experienced ASDR reductions of 24.8% and 47.4%, while Asia saw a 38.6% increase. AA mortality remained high in regions with high income, advanced health system, and high socio-demographic index, especially in aged population. In 2021, Japan reported the most AA-related deaths (23,815, 95% UI: 19,180-26,463) and Armenia had the highest ASDR (9.16 per 100,000, 95% UI: 7.61-10.81). Our results highlight significant sex differences in AA-related mortality. Men had nearly twice the ASDR of women, though the gap narrowed over time. The impact varied by age and region. ASDR declined more in men in Europe and America, especially in Sweden, Norway and Denmark. However, in Russia, Japan and Nauru, women saw greater increase, influencing overall AA-caused mortality. AA-related risk factors differ by sex: smoking is the primary risk factors for men, while high systolic blood pressure is more significant for women. Other risk factors include high body-mass index, diets low in fruits and vegetables, increased sodium intake and lead exposure. Importantly, the relative contribution of these risk factors has shifted over time, reflecting changes in lifestyle, public health policies, and healthcare access. Conclusion AA-related mortality remains a global burden with regional and sex disparities. Declines of AA-related ASDR in Western Europe and the America suggest effective interventions, while increases in Eastern Europe, Central and South Asia, and Japan, especially among women, highlight emerging challenges. Smoking, hypertension, and obesity are key contributors, emphasizing the need for targeted prevention, screening and healthcare access.
Open AccessGlobal Trends and Risk Factors of Aortic Aneurysm Mortality from 1990 to 2021: An Analysis of the Global Burden of Disease Study 2021
Background Aortic aneurysm (AA) is a life-threatening disease with significant global burden. Objectives This study aims to evaluate epidemiological trends and risk factors for AA-related mortality from 1990 to 2021 across regions, accounting for age, sex, and socio-economic factors. Methods Using Global Burden of Disease (GBD) Study 2021, we analyzed AA-related death, death rates, and the age-standardized AA-related death rate (ASDR) per 100,000, along with risk factors. Trends from 1990 to 2021 were compared across global regions and countries by socio-demographic index, health systems, and income. We also examined the impact and trend changes of age, sex, and risk factors on AA. Results In 2021, global AA-related deaths reached 153,927 (95% uncertainty intervals (UI): 138,413-165,738), a 74.2% increase from 1990. However, accounting for changes in population size and age, ASDR declined from 2.54 (95%UI: 2.35-2.69) to 1.86 (95%UI: 1.67-2.00) deaths per 100,000 people. Europe and America experienced ASDR reductions of 24.8% and 47.4%, while Asia saw a 38.6% increase. AA mortality remained high in regions with high income, advanced health system, and high socio-demographic index, especially in aged population. In 2021, Japan reported the most AA-related deaths (23,815, 95% UI: 19,180-26,463) and Armenia had the highest ASDR (9.16 per 100,000, 95% UI: 7.61-10.81). Our results highlight significant sex differences in AA-related mortality. Men had nearly twice the ASDR of women, though the gap narrowed over time. The impact varied by age and region. ASDR declined more in men in Europe and America, especially in Sweden, Norway and Denmark. However, in Russia, Japan and Nauru, women saw greater increase, influencing overall AA-caused mortality. AA-related risk factors differ by sex: smoking is the primary risk factors for men, while high systolic blood pressure is more significant for women. Other risk factors include high body-mass index, diets low in fruits and vegetables, increased sodium intake and lead exposure. Importantly, the relative contribution of these risk factors has shifted over time, reflecting changes in lifestyle, public health policies, and healthcare access. Conclusion AA-related mortality remains a global burden with regional and sex disparities. Declines of AA-related ASDR in Western Europe and the America suggest effective interventions, while increases in Eastern Europe, Central and South Asia, and Japan, especially among women, highlight emerging challenges. Smoking, hypertension, and obesity are key contributors, emphasizing the need for targeted prevention, screening and healthcare access.
- Open Access
Lipoprotein retention and inflammation due to regurgitant blood flow as part of the natural history of degenerative ascending aortic aneurysms
BACKGROUND: An abnormal accumulation of immune cells and a disrupted lipoprotein metabolism has previously been described as part of the pathogenesis of ascending aortic aneurysm in patients with tricuspid aortic valves. The factor driving the accumulation of immune cells remains unclear; however, it may be considered in light of the observation that proximal aortic dilatation often occurs alongside aortic regurgitation but rarely with aortic stenosis. In the present study we aim to investigate the natural history of ascending aortic aneurysm in patients with tricuspid aortic valves by assessing the association between aortic regurgitation and vascular deterioration. MATERIAL AND METHODS: Patients tricuspid aortic valves undergoing elective open- heart surgery for ascending aortic- and/or aortic valve replacement were included. Aortic specimens from organ donors were obtained through the University of Miami Tissue Bank, USA. Protein expression/localization and differences in aortic intima-media gene expression were assessed using immunohistochemistry and transcriptomics, respectively. Ten-year aortic growth was measured using echocardiography. In total 142 patients were included across experiments (mRNA expression n=44, immunohistochemistry n=49, 10-year follow-up n=49). RESULTS: Aortic regurgitation was associated with the presence of oxidized apolipoprotein B-containing lipoproteins and infiltrating CD68+ cells in the non-dilated ascending aortic media, which was not observed in aortas of patients with aortic stenosis. Assessing factors influencing lipoprotein retention showed increased levels of genes encoding core proteins of proteoglycans ( HSPG2, CSPG4, ACAN , and BGN ) in patients with regurgitant valves, compared with aortas from patients with stenotic valves. Moreover, dilated aortas of patients with aortic regurgitation exhibited higher levels of the receptor for oxidized low-density lipoprotein, OLR1 , which correlated positively with inflammatory markers in both dilated and non-dilated aortas. Surgical replacement of regurgitant aortic valves mitigated long-term aortic growth, in contrast to replacement of stenotic valves, which was associated with continuous aortic dilation. CONCLUSIONS: The natural history of ascending aortic aneurysm in patients with tricuspid aortic valves involves medial lipoprotein retention and oxidation with subsequent OLR1 -driven pathological inflammation, and can be mitigated by replacement of the regurgitant aortic valve.
Open AccessLipoprotein retention and inflammation due to regurgitant blood flow as part of the natural history of degenerative ascending aortic aneurysms
BACKGROUND: An abnormal accumulation of immune cells and a disrupted lipoprotein metabolism has previously been described as part of the pathogenesis of ascending aortic aneurysm in patients with tricuspid aortic valves. The factor driving the accumulation of immune cells remains unclear; however, it may be considered in light of the observation that proximal aortic dilatation often occurs alongside aortic regurgitation but rarely with aortic stenosis. In the present study we aim to investigate the natural history of ascending aortic aneurysm in patients with tricuspid aortic valves by assessing the association between aortic regurgitation and vascular deterioration. MATERIAL AND METHODS: Patients tricuspid aortic valves undergoing elective open- heart surgery for ascending aortic- and/or aortic valve replacement were included. Aortic specimens from organ donors were obtained through the University of Miami Tissue Bank, USA. Protein expression/localization and differences in aortic intima-media gene expression were assessed using immunohistochemistry and transcriptomics, respectively. Ten-year aortic growth was measured using echocardiography. In total 142 patients were included across experiments (mRNA expression n=44, immunohistochemistry n=49, 10-year follow-up n=49). RESULTS: Aortic regurgitation was associated with the presence of oxidized apolipoprotein B-containing lipoproteins and infiltrating CD68+ cells in the non-dilated ascending aortic media, which was not observed in aortas of patients with aortic stenosis. Assessing factors influencing lipoprotein retention showed increased levels of genes encoding core proteins of proteoglycans ( HSPG2, CSPG4, ACAN , and BGN ) in patients with regurgitant valves, compared with aortas from patients with stenotic valves. Moreover, dilated aortas of patients with aortic regurgitation exhibited higher levels of the receptor for oxidized low-density lipoprotein, OLR1 , which correlated positively with inflammatory markers in both dilated and non-dilated aortas. Surgical replacement of regurgitant aortic valves mitigated long-term aortic growth, in contrast to replacement of stenotic valves, which was associated with continuous aortic dilation. CONCLUSIONS: The natural history of ascending aortic aneurysm in patients with tricuspid aortic valves involves medial lipoprotein retention and oxidation with subsequent OLR1 -driven pathological inflammation, and can be mitigated by replacement of the regurgitant aortic valve.
- Open Access
- 10 May 2023
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 101 (7) , 801-811
Bicuspid aortic valve aortopathy is characterized by embryonic epithelial to mesenchymal transition and endothelial instability
Bicuspid aortic valve (BAV) is the most common congenital heart malformation frequently associated with ascending aortic aneurysm (AscAA). Epithelial to mesenchymal transition (EMT) may play a role in BAV-associated AscAA. The aim of the study was to investigate the type of EMT associated with BAV aortopathy using patients with a tricuspid aortic valve (TAV) as a reference. The state of the endothelium was further evaluated. Aortic biopsies were taken from patients undergoing open-heart surgery. Aortic intima/media miRNA and gene expression was analyzed using Affymetrix human transcriptomic array. Histological staining assessed structure, localization, and protein expression. Migration/proliferation was assessed using ORIS migration assay. We show different EMT types associated with BAV and TAV AscAA. Specifically, in BAV-associated aortopathy, EMT genes related to endocardial cushion formation were enriched. Further, BAV vascular smooth muscle cells were less proliferative and migratory. In contrast, TAV aneurysmal aortas displayed a fibrotic EMT phenotype with medial degenerative insults. Further, non-dilated BAV aortas showed a lower miRNA-200c-associated endothelial basement membrane LAMC1 expression and lower CD31 expression, accompanied by increased endothelial permeability indicated by increased albumin infiltration. Embryonic EMT is a characteristic of BAV aortopathy, associated with endothelial instability and vascular permeability of the non-dilated aortic wall. Key messages: Embryonic EMT is a feature of BAV-associated aortopathy. Endothelial integrity is compromised in BAV aortas prior to dilatation. Non-dilated BAV ascending aortas are more permeable than aortas of tricuspid aortic valve patients.
- 10 May 2023
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 101 (7) , 801-811
Open AccessBicuspid aortic valve aortopathy is characterized by embryonic epithelial to mesenchymal transition and endothelial instability
Bicuspid aortic valve (BAV) is the most common congenital heart malformation frequently associated with ascending aortic aneurysm (AscAA). Epithelial to mesenchymal transition (EMT) may play a role in BAV-associated AscAA. The aim of the study was to investigate the type of EMT associated with BAV aortopathy using patients with a tricuspid aortic valve (TAV) as a reference. The state of the endothelium was further evaluated. Aortic biopsies were taken from patients undergoing open-heart surgery. Aortic intima/media miRNA and gene expression was analyzed using Affymetrix human transcriptomic array. Histological staining assessed structure, localization, and protein expression. Migration/proliferation was assessed using ORIS migration assay. We show different EMT types associated with BAV and TAV AscAA. Specifically, in BAV-associated aortopathy, EMT genes related to endocardial cushion formation were enriched. Further, BAV vascular smooth muscle cells were less proliferative and migratory. In contrast, TAV aneurysmal aortas displayed a fibrotic EMT phenotype with medial degenerative insults. Further, non-dilated BAV aortas showed a lower miRNA-200c-associated endothelial basement membrane LAMC1 expression and lower CD31 expression, accompanied by increased endothelial permeability indicated by increased albumin infiltration. Embryonic EMT is a characteristic of BAV aortopathy, associated with endothelial instability and vascular permeability of the non-dilated aortic wall. Key messages: Embryonic EMT is a feature of BAV-associated aortopathy. Endothelial integrity is compromised in BAV aortas prior to dilatation. Non-dilated BAV ascending aortas are more permeable than aortas of tricuspid aortic valve patients.